Trials / Unknown
UnknownNCT05427903
Two Approaches in Enhancing the Efficacy of Inferior Alveolar Nerve Block During Treatment of Mandibular First Permanent Molars With Symptomatic Irreversible Pulpitis
Evaluation of Two Approaches in Enhancing the Efficacy of Inferior Alveolar Nerve Block During Treatment of Mandibular First Permanent Molars With Symptomatic Irreversible Pulpitis: A Randomized Parallel Controlled Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 180 (estimated)
- Sponsor
- Minia University · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
The study is designed as a randomized parallel controlled trial with three groups. Participants aged above 18 years with the first permanent molars with symptomatic signs of irreversible pulpitis will be randomly assigned into 3 groups. The first group (experimental group) will be injected with 4% articaine 1:100.000 epinephrine (inferior alveolar nerve block) will be anesthetized using 4% articaine 1:100.000 plus cryotherapy application, and the second group (experimental group) will be anaesthetised with IANB plus buccal infiltration. For the third group (control group), the mandibular molars will be anaesthetized using epinephrine using the inferior alveolar nerve block.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Cryotherapy | Ice packs application for 5 minutes after IANB injection |
| PROCEDURE | Buccal local anesthetic infiltration using articaine 4% 1:100000 epinephrine | Buccal infiltration after IANB |
Timeline
- Start date
- 2022-03-04
- Primary completion
- 2022-06-18
- Completion
- 2022-07-01
- First posted
- 2022-06-22
- Last updated
- 2022-06-22
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05427903. Inclusion in this directory is not an endorsement.